Peripheral nervous system involvement in Parkinson's disease: Evidence and controversies

Keyphrases

• Parkinson's Disease 100%
• Peripheral Nervous System Involvement 100%
• Peripheral Neuropathy 80%
• Levodopa 60%
• Nave 20%
• Parkinson Patients 20%
• Basal Ganglia Disorders 20%
• Peripheral Nervous System 20%
• Levodopa Therapy 20%
• Alpha-synuclein (α-syn) 20%
• Disease-related 20%
• Dopaminergic Treatment 20%
• Small Nerve Fibers 20%
• Intestinal Infusion 20%
• Non-motor Features 20%
• Fiber Deterioration 20%
• Vitamin B Deficiency 20%
• Acute Peripheral Neuropathy 20%
• Systemic Features 20%
• B-group Vitamins 20%

Neuroscience

• Parkinson's Disease 100%
• Peripheral Nervous System 100%
• Neuropathy 83%
• L-DOPA 66%
• Nerve Fiber 16%
• Dopaminergic 16%
• Basal Ganglia 16%
• Synuclein 16%
• Vitamin Deficiency 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Parkinson's Disease 100%
• Neuropathy 83%
• Levodopa 66%
• Disease 33%
• Case-Control Study 16%
• Dopamine Receptor Stimulating Agent 16%
• Deterioration 16%
• Vitamin Deficiency 16%
• Synuclein 16%